RxDoctor Payments Data

Daniel Berg, MD

Family Medicine · Bethalto, ILNPI 1164817722

Payments from drug & device makers

$1,399in general payments, 2019–2025

Across 76 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$410
  • Lilly USA, LLC$220
  • Amgen$125
  • Novo Nordisk$101
  • Pfizer$96
  • Exact Sciences$89
  • plus $357 from 9 others

What the payments were for

  • Food & beverage$1,399100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,399 in reported general payments places this provider in the 75th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$97,152
Medicare patients
623
Services billed
1,344

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban119$132,187
OzempicSemaglutide111$127,859
JardianceEmpagliflozin97$117,437
MounjaroTirzepatide56$70,338
Trelegy ElliptaFluticasone/Umeclidin/Vilanter66$49,259
XareltoRivaroxaban42$37,264
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr76$33,995
RybelsusSemaglutide12$32,696
EntrestoSacubitril/Valsartan32$27,189
JanuviaSitagliptin Phosphate19$26,759
Tresiba Flextouch U-200Insulin Degludec14$26,603
MyrbetriqMirabegron18$18,107
UbrelvyUbrogepant13$13,861
TrulicityDulaglutide13$12,863
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl51$10,082

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$101$160,555123 claims
PfizerEliquis$96$132,187119 claims
Boehringer IngelheimJardiance$73$117,43797 claims
GSKTrelegy Ellipta, Anoro Ellipta$41$83,254142 claims
Lilly USA, LLCMounjaro, Trulicity$220$83,20169 claims
Johnson & JohnsonXarelto$20$37,26442 claims
NovartisEntresto$59$27,18932 claims
Astellas Pharma US IncMyrbetriq$28$18,10718 claims
AbbVieUbrelvy$410$13,86113 claims
AstraZenecaSymbicort$62$3,87013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Bethalto

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →